Thermo Fisher Scientific

Nalgene
Waltham, Massachusetts
Pharmaceuticals Biotechnology and Life Sciences

Corporate Bias Rating

Expand Summary

Risk Level:

Rating - Danger
High Risk

Summary:

Thermo Fisher scored a 100 out of 100 on the 2023-2024 Corporate Equality Index (CEI) from the Human Rights Campaign (HRC), a political stakeholder group. By complying with the HRC’s controversial demands, the company increases the risk of dividing employees, alienating customers and harming shareholders. The company provides a benefits package for employees which covers transgender medical procedures for covered employees and dependents, including children. It also uses sex and gender ideology criteria in employee recruitment, vendor selection, marketing, and philanthropic support. Thermo Fisher forces employees to undergo multiple ideological trainings and uses its reputation, corporate funds, and political influence to support controversial sex and gender ideologies, organizations, and legislation. The company supports the Equality Act, a controversial bill. Thermo Fisher signed an amicus brief in opposition to the 2016 North Carolina bathroom bill HB2, which required people to use the bathroom of their biological sex. The company opposed the Florida Parental Rights in Education Act, which would prohibit teaching gender identity and sexual orientation to kids in K-3rd grade. Thermo Fisher opposed various state and local legislation intended to protect parental rights, girls’ sports, bathroom facilities, and gendered spaces. The company opposed legislation in Iowa intended to protect parental rights, girls’ sports, bathroom facilities, and gendered spaces. Thermo Fisher’s CEO, Marc Casper, signed the CEO Action for Diversity & Inclusion pledge, which includes a commitment to promote DEI through bias education training in the workplace. Thermo Fisher is a member of the MCCA, indicating its focus on recruiting, retaining, and promoting employees based on race. For these reasons, Thermo Fisher Scientific receives a High Risk rating.

View Full Corporate Bias Ratings Report

Board Bias

Expand Summary

CEO of Thermo Fisher Scientific

Marc N. Casper

Marc N. Casper

Summary:

Headquartered in Waltham, Massachusetts, Thermo Fisher Scientific is a member of the Fortune 250 operating in the Pharmaceuticals Biotechnology and Life Sciences industry. Marc N. Casper and Marc N. Casper serve as CEO/President and Chairman, respectively, leading the company’s C-suite executive team and the board of directors. Amongst these teams, the collective leadership is responsible for $819,857 to Republican causes and $404,769 to Democratic causes. Under their tenure, Thermo Fisher Scientific currently holds a 'High Risk' risk rating.

View Full Board Bias Report

Political Contributions of Leadership:

$819,857

$404,769

Republican

Democrat

Generate Reports
Clear
Toast